Recommended Reading

Google Search

Charts courtesy of

Monday, January 9, 2012


There were a bunch of biotech stocks making huge breakout moves today, one on a buyout, s few more on drug tests, and ACHN, which is a combination of the two. It did have a successful drug test but, according to the reports I read, is strongly suspected of being a buyout target. Notice how it came right up to the target projected for it by the previous two pivot points: I suspect it's not going to go much higher than that.

No comments:

Google Analytics